HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mika Watanabe Selected Research

Lactic Acid (Lactate)

4/2017Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration.
8/2010Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
4/2005201Tl-SPECT and 1H-MRS study of benign lateral ventricle tumors: differential diagnosis of subependymoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mika Watanabe Research Topics

Disease

92Neoplasms (Cancer)
10/2022 - 01/2003
26Breast Neoplasms (Breast Cancer)
03/2018 - 03/2006
24Neoplasm Metastasis (Metastasis)
05/2022 - 01/2005
16Carcinoma (Carcinomatosis)
01/2021 - 02/2004
14Glioma (Gliomas)
07/2021 - 04/2003
11Glioblastoma (Glioblastoma Multiforme)
01/2019 - 07/2007
9Lymphatic Metastasis
01/2019 - 02/2004
8Noninfiltrating Intraductal Carcinoma (DCIS)
07/2017 - 03/2006
7Disease Progression
07/2022 - 04/2006
7Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 08/2013
6Aortic Valve Stenosis (Aortic Stenosis)
10/2021 - 07/2020
6Brain Neoplasms (Brain Tumor)
01/2020 - 04/2011
5Adenoma (Adenomas)
07/2022 - 05/2009
5Sarcoma (Soft Tissue Sarcoma)
10/2021 - 07/2008
5Inflammation (Inflammations)
01/2021 - 05/2004
5Necrosis
08/2020 - 09/2009
5Hemorrhage
06/2020 - 11/2009
5Cysts
06/2020 - 01/2009
5Craniopharyngioma (Craniopharyngiomas)
01/2020 - 06/2013
5Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2018 - 07/2007
5Adenocarcinoma
04/2017 - 10/2012
5Ductal Carcinoma
05/2014 - 02/2004
4Pituitary Neoplasms (Pituitary Adenoma)
11/2022 - 01/2013
4Astrocytoma (Pilocytic Astrocytoma)
06/2020 - 08/2010
4Hypoxia (Hypoxemia)
11/2016 - 11/2006
4Oligodendroglioma
10/2016 - 07/2007
4Gastritis
03/2014 - 04/2011
3Hyperplasia
09/2021 - 05/2015
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 05/2011
3Hydrocephalus (Hydrocephaly)
09/2018 - 09/2011
3Germinoma
07/2018 - 01/2014
3Meningioma (Meningiomas)
10/2016 - 12/2014
3Endometrial Neoplasms (Endometrial Cancer)
01/2016 - 12/2012
3Neuroepithelial Neoplasms (Gliomatosis Cerebri)
05/2013 - 08/2008
3Stomach Neoplasms (Stomach Cancer)
12/2012 - 01/2004
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2011 - 11/2005
2Fever (Fevers)
05/2022 - 01/2018
2Actinomycosis
04/2022 - 05/2007

Drug/Important Bio-Agent (IBA)

20Biological ProductsIBA
07/2021 - 02/2004
20Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2005
11Biomarkers (Surrogate Marker)IBA
06/2021 - 04/2006
10Estrogen ReceptorsIBA
12/2016 - 02/2004
10Progesterone Receptors (Progesterone Receptor)IBA
03/2016 - 02/2004
9Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2021 - 12/2012
8Hormones (Hormone)IBA
07/2022 - 03/2006
8Estrogens (Estrogen)FDA Link
10/2015 - 06/2010
6GadoliniumIBA
01/2019 - 09/2002
6Messenger RNA (mRNA)IBA
03/2015 - 04/2010
6Keratins (Keratin)IBA
09/2013 - 05/2006
5AndrogensIBA
03/2018 - 06/2010
5Protons (Proton)IBA
01/2017 - 04/2003
5SteroidsIBA
04/2016 - 06/2005
5Phenobarbital (Luminal)FDA Link
03/2016 - 03/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2022 - 11/2006
4Small Interfering RNA (siRNA)IBA
06/2021 - 01/2016
4Formaldehyde (Formol)FDA Link
04/2021 - 12/2010
4Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2021 - 08/2013
4Irinotecan (Camptosar)FDA LinkGeneric
04/2021 - 08/2013
4AcidsIBA
01/2020 - 04/2011
4Pharmaceutical PreparationsIBA
01/2020 - 07/2012
4LipidsIBA
12/2018 - 04/2005
4Androgen Receptors (Androgen Receptor)IBA
03/2018 - 06/2005
4ErbB Receptors (EGF Receptor)IBA
01/2017 - 06/2010
4AntibodiesIBA
01/2017 - 06/2009
4Cisplatin (Platino)FDA LinkGeneric
12/2015 - 06/2007
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2015 - 07/2007
4NimustineIBA
04/2013 - 11/2009
3CollagenIBA
10/2022 - 01/2009
3ParaffinIBA
04/2021 - 12/2010
3VimentinIBA
10/2018 - 01/2003
3Tumor Biomarkers (Tumor Markers)IBA
07/2018 - 03/2003
3Temozolomide (Temodar)FDA LinkGeneric
04/2018 - 05/2014
3CytokinesIBA
01/2018 - 05/2008
3IfosfamideFDA LinkGeneric
11/2017 - 09/2011
3Lactic Acid (Lactate)FDA LinkGeneric
04/2017 - 04/2005
3Trastuzumab (Herceptin)FDA Link
01/2017 - 09/2015
3Etoposide (VP 16)FDA LinkGeneric
01/2016 - 09/2011
3Oxidoreductases (Dehydrogenase)IBA
06/2015 - 04/2014
3Aromatase (CYP19)IBA
07/2014 - 06/2010
3Pepsinogen A (Pepsinogen)IBA
03/2014 - 04/2011
3Choline (Choline Chloride)IBA
01/2014 - 04/2005
3Estradiol (Delestrogen)FDA LinkGeneric
10/2013 - 10/2010
3EnzymesIBA
10/2013 - 11/2009
2Therapeutic UsesIBA
06/2022 - 01/2017
2Prednisolone (Predate)FDA LinkGeneric
06/2022 - 01/2020
2Bevacizumab (Avastin)FDA Link
05/2022 - 05/2014
2Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 05/2007
2pazopanibFDA Link
10/2021 - 06/2021

Therapy/Procedure

28Therapeutics
07/2022 - 09/2005
22Drug Therapy (Chemotherapy)
05/2022 - 02/2006
14Radiotherapy
06/2020 - 04/2006
10Transcatheter Aortic Valve Replacement
08/2021 - 01/2020
5Lymph Node Excision (Lymph Node Dissection)
06/2022 - 09/2012
5Craniotomy
01/2019 - 11/2007
5Aftercare (After-Treatment)
11/2016 - 11/2006
4Chemoradiotherapy
04/2013 - 01/2008
3Curettage
10/2022 - 03/2006
3Stents
01/2018 - 01/2013
3Hysterectomy
11/2017 - 09/2012
3Quantum Dots (Quantum Dot)
10/2016 - 09/2012